Your browser doesn't support javascript.
loading
Cost saving of 5-day therapy with cefpodoxime proxetil versus standard 10-day beta-lactam therapy for recurrent pharyngotonsillitis in adults. A prospective general practice study.
Pelc, A; Portier, H; Gehanno, P; Fiessinger, S; Ichou, F.
Affiliation
  • Pelc A; Health Economics Department, IMS International, Montrouge, France.
Pharmacoeconomics ; 10(3): 239-50, 1996 Sep.
Article in En | MEDLINE | ID: mdl-10172792
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Prodrugs / Ceftizoxime / Pharyngitis / Tonsillitis / Drug Therapy, Combination / Anti-Bacterial Agents Type of study: Clinical_trials / Health_economic_evaluation / Risk_factors_studies Limits: Adult / Humans Country/Region as subject: Europa Language: En Journal: Pharmacoeconomics Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 1996 Document type: Article Affiliation country: Francia Country of publication: Nueva Zelanda
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Prodrugs / Ceftizoxime / Pharyngitis / Tonsillitis / Drug Therapy, Combination / Anti-Bacterial Agents Type of study: Clinical_trials / Health_economic_evaluation / Risk_factors_studies Limits: Adult / Humans Country/Region as subject: Europa Language: En Journal: Pharmacoeconomics Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 1996 Document type: Article Affiliation country: Francia Country of publication: Nueva Zelanda